Rep. Robert Bresnahan, Jr. Sells UnitedHealth Group Incorporated (NYSE:UNH) Shares

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on February 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on January 13th. The trade occurred in the Representative’s “JOINT OWNERSHIP LPL ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of Lowe’s Companies (NYSE:LOW) on 2/7/2025.
• Purchased $1,001 – $15,000 in shares of Intel (NASDAQ:INTC) on 2/3/2025.
• Purchased $1,001 – $15,000 in shares of Take-Two Interactive Software (NASDAQ:TTWO) on 2/3/2025.
• Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 2/3/2025.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of Manhattan Associates (NASDAQ:MANH) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of NVIDIA (NASDAQ:NVDA) on 1/29/2025.

UnitedHealth Group Stock Performance

Shares of UNH traded down $7.70 during mid-day trading on Friday, reaching $523.48. The company’s stock had a trading volume of 3,703,659 shares, compared to its average volume of 4,348,924. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock has a market cap of $481.75 billion, a P/E ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61. The business has a 50-day simple moving average of $523.11 and a two-hundred day simple moving average of $563.18. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $5.83 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Institutional Investors Weigh In On UnitedHealth Group

A number of hedge funds and other institutional investors have recently bought and sold shares of UNH. AMF Tjanstepension AB lifted its holdings in UnitedHealth Group by 88.0% during the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after buying an additional 121,180 shares during the period. Hudson Value Partners LLC lifted its holdings in UnitedHealth Group by 8.3% during the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after buying an additional 82 shares during the period. Wealth Group Ltd. lifted its stake in shares of UnitedHealth Group by 4.0% in the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after purchasing an additional 68 shares during the period. Creative Planning lifted its stake in shares of UnitedHealth Group by 11.0% in the 3rd quarter. Creative Planning now owns 212,295 shares of the healthcare conglomerate’s stock valued at $123,025,000 after purchasing an additional 21,114 shares during the period. Finally, Zhang Financial LLC lifted its stake in shares of UnitedHealth Group by 18.1% in the 3rd quarter. Zhang Financial LLC now owns 667 shares of the healthcare conglomerate’s stock valued at $390,000 after purchasing an additional 102 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on UNH. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. TD Cowen raised their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is owned by company insiders.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.